Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Circulating Tumor CellNasopharyngeal CarcinomaDistant Metastases.ClinicalEffects of Chemotherapy
Interventions
DRUG

cisplatin-based chemotherapy

"GP: cisplatin 80 mg/m2 intravenous infusion on day1, gemcitabine 1000 mg/m2 intravenous infusion on day 1 and 8, both drugs are given every 3 weeks, recommended 6 cycles.~TP: cisplatin 75 mg/m2 intravenous infusion in day1, docetaxel 75 mg/m2 intravenous infusion in day 1, both drugs are given every 3 weeks, recommended 6 cycles.~PF: cisplatin 100 mg/m2 intravenous infusion in day1, fluorouracil 4000 mg/m2 intravenous infusion in day 1 to 5, both drugs are given every 3 weeks, recommended 6 cycles.~TPF: cisplatin 60 mg/m2 intravenous infusion in day1, docetaxel 60 mg/m2 intravenous infusion in day 1, fluorouracil 3000 mg/m2 intravenous infusion in day 1 to 5, both drugs are given every 3 weeks, recommended 6 cycles.~Choice of chemotherapy regimen is decided by patient's doctor in charge."

Trial Locations (1)

510060

RECRUITING

Cancer Center, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER